FDA Expands Indication for Fluarix Quadrivalent Flu Vaccine

Share this post

GlaxoSmithKline’s four-strain influenza vaccine Fluarix is now indicated to help prevent influenza in children as young as 6 months.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply